CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated deficit	Accumulated other comprehensive loss
Balance (in shares) at Mar. 31, 2023		56,676,313
Balance at Mar. 31, 2023	$ 555,292	$ 57	$ 1,034,994	$ (485,488)	$ 5,729
Increase (decrease) in Stockholders' Equity
Foreign currency translation adjustment	(1,305)				(1,305)
Unrealized loss on short-term investments	(458)				(458)
Exercise of pre-funded warrants (in shares)		1,922,655
Exercise of stock options (in shares)		96,146
Exercise of stock options	1,209		1,209
Vesting of RSUs (in shares)		281,211
Stock-based compensation expense	8,846		8,846
Net loss	(49,555)			(49,555)
Balance (in shares) at Jun. 30, 2023		58,976,325
Balance at Jun. 30, 2023	514,029	$ 57	1,045,049	(535,043)	3,966
Balance (in shares) at Mar. 31, 2024		61,415,105
Balance at Mar. 31, 2024	374,508	$ 61	1,070,874	(701,282)	4,855
Increase (decrease) in Stockholders' Equity
Issuance of prefunded warrants to purchase common stock, net of issuance costs	48,500		48,500
Issuance of common stock, net of issuance costs and underwriter fees (in shares)		5,668,937
Issuance of common stock in connection with private placement, net of placement agent fees and offering costs	48,204	$ 6	48,198
Foreign currency translation adjustment	(432)				(432)
Unrealized loss on short-term investments	(99)				(99)
Exercise of pre-funded warrants (in shares)		739,225
Exercise of pre-funded warrants	$ 1	$ 1
Exercise of stock options (in shares)	22,860	22,860
Exercise of stock options	$ 66		66
Vesting of RSUs (in shares)		463,841
Vesting of RSUs	0
Stock-based compensation expense	9,475		9,475
Net loss	(53,772)			(53,772)
Balance (in shares) at Jun. 30, 2024		68,309,968
Balance at Jun. 30, 2024	$ 426,451	$ 68	$ 1,177,113	$ (755,054)	$ 4,324